Меню
Идёт набор NCT05968573

Persuasive Health Communication Intervention for HIV/HCV

Без фазы С лечением Human Immunodeficiency Virus (HIV) Hepatitis C (HCV)

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Video Format with Captions, Video Format without Captions, Health Educator.
Кому может быть актуально
Состояния в реестре: Human Immunodeficiency Virus (HIV), Hepatitis C (HCV). Базовые параметры: от 18 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
США
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

Evaluation of a Persuasive Health Communication Intervention Designed to Increase HIV/HCV Screening Among Emergency Departments Patients Who Currently, Formerly or Never Injected Drugs.

Обзор

A major impediment to emergency department (ED)-based HIV/HCV screening success is that often ED patients at risk for, or later diagnosed with, HIV and HCV decline testing. In this R01 project, the research team will assess how well a promising, easy-to-use, one-time, minimal-training-needed, very brief persuasive health communication intervention (PHCI) increases acceptance of testing among adult ED patients who either currently, formerly or never injected drugs and initially declined HIV/HCV screening. The research team will conduct a randomized, controlled trial (RCT) at EDs within the Mount Sinai Health System to compare the efficacy of the PHCI when delivered by a video vs. an HIV/HCV counselor. Patients who initially declined HIV/HCV screening will be stratified by injection-drug use (IDU) history cohorts: (1) current/former PWIDs, (2) never/non-PWIDs. Within each IDU history cohort, the research team will randomly assign participants (1:1:1) to a PHCI delivered by: (1) a video with captions, (2) a video without captions, (3) an HIV/HCV counselor. This R01 project will be conducted at Mount Sinai affiliate hospitals EDs. For Aim 2, the research team will determine if screening acceptance is similar across IDU history cohorts. For Aim 3, the research team will further compare the two delivery forms of the PHCI through a health economics assessment, both independent of IDU history and within each IDU history cohort.

Подробное описание

As part of routine practice at Mount Sinai Health System EDs, the ED Nurses initiate HIV/HCV screening for all patients able to provide consent. ED patients eligible for recruitment into the RCT portion of the study are those who declined HIV/HCV screening. RCs will review the electronic health records (EHRs) of patients present in the ED during data collection periods and determine which patients are potentially eligible.

Participation in the RCT involves a one-time encounter. All research-related activities will occur in the ED. As such, drop-out during this brief RCT (\<30 minutes from recruitment through final study questionnaires) is expected to be minimal (\<5%). RCs will coordinate with participants and ED staff to facilitate participant involvement while they are receiving medical care. If necessary, participants can continue participating in designated areas of the ED (e.g., waiting room, family room) after they are discharged and there are study-related tasks remaining. There are no research related follow-ups needed.

The research team will enroll a total of 2,000 adult ED patients who meet all study criteria and agree to participate in the RCT, stratified by IDU history. Assuming 0.6 participants completing the study/hour (1 study completion/75 minutes of recruitment, enrollment, and data collection), the research team could recruit up to ≈5,184 participants (720 collection days x 12 hours/data collection/day x 0.6 participants/hour) over 3 years.

The research team will be collecting data using the QDS™ (NOVA Research Company) program installed on a tablet computer. The program has the ability to encrypt collected data, to which only the researcher has ability to de-crypt data sets (NOVA Research cannot recover lost passwords for the researcher). The program also has a data management system, allowing data export for use in analytical packages like SPSS, Stata. Internet access is not necessary for this program to function. The data can be stored on the tablet computer for the meantime, then synced once internet is available.

Вмешательства

  • Другое Video Format with Captions
    A video with captions created by the research team will be played to persuade patients to participate in HIV and Hepatitis C (HCV) screening.
  • Другое Video Format without Captions
    A video without captions created by the research team will be played to persuade patients to participate in HIV and Hepatitis C (HCV) screening.
  • Другое Health Educator
    The video created by the research will be compared to a healthcare provider in terms of effectiveness in getting patients screened for HIV/HCV.

Первичные конечные точки

  • Number of patients who accept HIV/HCV testing after watching the video with captions [Срок оценки: Day 1, up to 5 minutes after intervention]
  • Number of patients who accept HIV/HCV testing after watching the video without captions [Срок оценки: Day 1, up to 5 minutes after intervention]
  • Number of patients who accept HIV/HCV testing after speaking with a health educator [Срок оценки: Day 1, up to 5 minutes after intervention]
Вторичные конечные точки (4)
  • The number of patients that accept HIV/HCV testing by no prior injection-drug use [Срок оценки: Day 1, up to 5 minutes after intervention]
  • The number of patients that accept HIV/HCV testing by former injection-drug use [Срок оценки: Day 1, up to 5 minutes after intervention]
  • The number of patients that accept HIV/HCV testing by current injection-drug use [Срок оценки: Day 1, up to 5 minutes after intervention]
  • Health economics assessment of PHCI [Срок оценки: End of study, at 5 years]

Критерии участия

Критерии включения

  • ≥18 years-old
  • Speak English or Spanish, and able to provide informed consent for study participation
  • Not HIV AND HCV infected/Antibody+ (per EHR review and patient report)
  • Not already participating in a HIV or HCV study (e.g., HIV PrEP, HIV vaccine)
  • Not tested for HIV OR HCV within the past 12 months (per EHR review and patient report)

Критерии исключения

  • <18 years old
  • Unable to speak Spanish or English
  • HIV or HCV positive
  • Currently enrolled in another HIV or HCV research study
  • Has tested for HIV or HCV in the past 12 months

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Да

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Открытое
Основная цель
Организация здравоохранения

Центры проведения

США · 1 центр
  • Icahn School of Medicine at Mount Sinai — New York

Публикации

  • Merchant RC, Harrington N, Clark MA, Liu T, Morgan J, Cowan E, Solnick R, Wyler B. Testing a persuasive health communication intervention (PHCI) for emergency department patients who declined rapid HIV/HCV screening: a randomised controlled trial study protocol. BMJ Open. 2024 Aug 12;14(8):e089265. doi: 10.1136/bmjopen-2024-089265. PMID 39134444

Идентификаторы

NCT: NCT05968573 · STUDY-22-01162 · 1R01DA055533-01

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗